Netarsudil plus latanoprost cuts diurnal IOP 2.36 mmHg vs latanoprost alone in Japanese glaucoma
Adding netarsudil to latanoprost lowers eye pressure faster in Japanese patients with glaucoma
This Phase III randomized controlled trial in 246 Japanese participants with primary open-angle glaucoma or ocular hypertension found that n…
Japanese patients with glaucoma saw lower eye pressure when adding netarsudil to their current latanoprost drops compared to a placebo plus …
Rho-kinase inhibitors reduce intraocular pressure by 9.32 mmHg at 3 months in uveitic glaucoma patients
Rho-kinase inhibitors lower eye pressure in uveitic glaucoma patients
This systematic review and meta-analysis evaluated Rho-kinase inhibitors for uveitic glaucoma or ocular hypertension secondary to uveitis. T…
A meta-analysis of 383 participants found Rho-kinase inhibitors significantly reduce eye pressure in uveitic glaucoma with a favorable safet…
Netarsudil shows lower IOP reduction but better conjunctival hyperemia profile versus prostaglandin analogues
New data shows netarsudil offers a safer option for some glaucoma patients
A Bayesian network meta-analysis found netarsudil ranked lower for IOP reduction but had a more favorable conjunctival hyperemia profile com…
A fresh look at glaucoma drugs shows one option causes less redness while still helping lower eye pressure effectively.